Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Desmet, P. Gosset, B. Pajak, V. Garzé, P. Lekeux, F. Bureau (Liège, Brussels, Belgium; Lille, France). Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation. Eur Respir J 2005; 26: Suppl. 49, 1592

Member's Comments

No comment yet.

Related content which might interest you: Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 The epidermal growth factor receptor mediates allergic airway remodelling in the rat Source: Eur Respir J 2008; 32: 1213-1223 Year: 2008 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Inhibitors of PDE4 delay eosinophil apoptosis Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Effects of pendrin inhibitor (PDI_C01) in vitro, and in vivo models of lipopolysaccharide-induced airway inflammation. Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019 Low power laser (LBP) therapy downregulates the allergic lung inflammation in experimental asthma model: Effect driven to signal transducer and activator of transduction 6 (STAT-6) Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007